diabetes insipidus
Information
- Disease name
- diabetes insipidus
- Disease ID
- DOID:9409
- Description
- "A kidney disease that is characterized by polydipsia and polyuria with a dilute urine having a specific gravity less than 1.010, hypernatremia, and dehydration." [url:https\://pubmed.ncbi.nlm.nih.gov/26913870/, url:https\://pubmed.ncbi.nlm.nih.gov/27156759/, url:https\://pubmed.ncbi.nlm.nih.gov/28476225/, url:https\://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7426034/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00004363 | Completed | Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus | December 1995 | ||
NCT02455414 | Completed | Tracking Neurodegeneration in Early Wolfram Syndrome | April 2012 | July 12, 2017 | |
NCT02523001 | Completed | Effect of Statin Treatment on Urinary AQP2 (uAQP2/01) | October 2013 | July 2015 | |
NCT03572166 | Completed | N/A | Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx Study | September 3, 2018 | December 31, 2022 |
NCT04550520 | Completed | N/A | Copeptin After a Subcutaneous Stimulation With Glucagon in Adults | September 28, 2020 | May 30, 2021 |
NCT04648137 | Completed | N/A | Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls | February 5, 2021 | April 11, 2022 |
NCT00757276 | Completed | Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study | June 2008 | October 2014 | |
NCT01940614 | Completed | Use of Copeptin in Diabetes Insipidus | July 2013 | December 2017 | |
NCT02132676 | Completed | Shared Health Appointments and Reciprocal Enhanced Support | April 25, 2016 | July 30, 2019 | |
NCT06368817 | Not yet recruiting | Phase 2 | A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | July 12, 2024 | November 4, 2033 |
NCT02841553 | Recruiting | Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study | July 2011 | April 2026 | |
NCT02460354 | Terminated | Phase 1 | Metformin and Congenital Nephrogenic Diabetes Insipidus | September 2015 | June 2017 |
NCT00004364 | Unknown status | Study of Novel Types of Familial Diabetes Insipidus | December 1995 | ||
NCT04351945 | Unknown status | Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors | May 20, 2020 | July 1, 2022 |
- Disase is a (Disease Ontology)
- DOID:557
- Cross Reference ID (Disease Ontology)
- ICD10CM:E23.2
- Cross Reference ID (Disease Ontology)
- ICD9CM:253.5
- Cross Reference ID (Disease Ontology)
- MESH:D003919
- Cross Reference ID (Disease Ontology)
- NCI:C43263
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:190484000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0011848
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000873
- ICD10 preferred id (Insert disease from ICD10)
- D0003697
- ICD10 class code (Insert disease from ICD10)
- E23.2
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003919